[#item_full_content] Trulieve Cannabis (CNSX:TRUL) just picked up a key regulatory win, with Texas granting its subsidiary conditional approval for a Dispensing Organization license under the Compassionate Use Program, opening the door to a major new medical market. See our latest analysis for Trulieve Cannabis. Despite this Texas catalyst, Trulieve’s 1 month share price return of minus 8.97 percent and 3 month share price return of minus 21.67 percent show momentum has recently cooled. Even though the 1 year… Read More
